nach oben

Inflammation

Erschienen in:

01.06.2015

Inhibiting Interleukin-18 Production Through the Mitogen-Activated Protein Kinase Pathway, A Potential Role of Corticotropin-Releasing Hormone in Chronic Plaque Psoriasis

verfasst von: Chun-Lei Zhou, Xiao-Jing Yu, Da-Xing Cai, Yong-Hao Xu, Chun-Yang Li, Qing Sun

Erschienen in: Inflammation | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Corticotropin-releasing hormone (CRH) and CRH receptors (CRH-Rs) are expressed in the skin; CRH-R1 is the predominant receptor. Whether the CRH/CRH-R1 system plays a role in psoriasis has not yet been assessed. Immunohistochemistry, real-time RT-PCR, ELISA assay, and Western blot analysis were used to investigate the expression of CRH/CRH-R1 in patients with chronic plaque psoriasis and that of IL-18 in CRH-treated HaCaT cells. CRH and CRH-R1 were downregulated in patients with chronic plaque psoriasis. In vitro, CRH attenuated the expression of IL-18 by a mitogen-activated protein kinase signaling pathway through CRH-R1 in HaCaT cells. Thus, an aberrant cutaneous CRH/CRH-R1 system exists in lesions from chronic plaque psoriasis which might play a role in psoriasis and offers further evidence for the study of CRH in the skin.

Arican, O., M. Aral, et al. 2005. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators of Inflammation 2005(5): 273–279.CrossRefPubMedCentralPubMed

Benou, C., Y. Wang, et al. 2005. Corticotropin-releasing hormone contributes to the peripheral inflammatory response in experimental autoimmune encephalomyelitis. Journal of Immunology 174(9): 5407–5413.CrossRef

Bonnekoh, B., C. Huerkamp, et al. 1995. Up-regulation of keratin 17 expression in human HaCaT keratinocytes by interferon-gamma. Journal of Investigative Dermatology 104(1): 58–61.CrossRefPubMed

Bonnekoh, B., A. Wevers, et al. 1991. Antiproliferative potential of zidovudine in human keratinocyte cultures. Journal of the American Academy of Dermatology 25(3): 483–490.CrossRefPubMed

Bowcock, A.M., and J.G. Krueger. 2005. Getting under the skin: The immunogenetics of psoriasis. Nature Reviews Immunology 5(9): 699–711.CrossRefPubMed

Companjen, A.R., V.H. van der Velden, et al. 2000. Human keratinocytes are major producers of IL-18: Predominant expression of the unprocessed form. European Cytokine Network 11(3): 383–390.PubMed

Dermitzaki, E., C. Tsatsanis, et al. 2002. Corticotropin-releasing hormone induces Fas ligand production and apoptosis in PC12 cells via activation of p38 mitogen-activated protein kinase. Journal of Biological Chemistry 277(14): 12280–12287.CrossRefPubMed

Flisiak, I., A. Klepacki, et al. 2006. Plasma and scales levels of interleukin 18 in comparison with other possible clinical and laboratory biomarkers of psoriasis activity. Biomarkers 11(2): 194–200.CrossRefPubMed

Ganceviciene, R., V. Graziene, et al. 2009. Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. British Journal of Dermatology 160(2): 345–352.CrossRefPubMed

10.

Gangemi, S., R.A. Merendino, et al. 2003. Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: Preliminary considerations. Journal of the European Academy of Dermatology and Venereology 17(1): 42–46.CrossRefPubMed

11.

Gaspari, A.A. 2006. Innate and adaptive immunity and the pathophysiology of psoriasis. Journal of the American Academy of Dermatology 54(3 Suppl 2): S67–80.CrossRefPubMed

12.

Gracie, J.A., S.E. Robertson, et al. 2003. Interleukin-18. Journal of Leukocyte Biology 73(2): 213–224.CrossRefPubMed

13.

Gupta, M.A., and A.K. Gupta. 2003. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: Epidemiology and management. American Journal of Clinical Dermatology 4(12): 833–842.CrossRefPubMed

14.

Johansen, C., K. Kragballe, et al. 2005. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. British Journal of Dermatology 152(1): 37–42.CrossRefPubMed

15.

Karalis, K., L.J. Muglia, et al. 1997. CRH and the immune system. Journal of Neuroimmunology 72(2): 131–136.CrossRefPubMed

16.

Kim, J.E., D.H. Cho, et al. 2007. Expression of the corticotropin-releasing hormone-proopiomelanocortin axis in the various clinical types of psoriasis. Experimental Dermatology 16(2): 104–109.CrossRefPubMed

17.

Kono, M., H. Nagata, et al. 2001. In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. Faseb Journal 15(12): 2297–2299.PubMed

18.

Mee, J.B., Y. Alam, et al. 2000. Human keratinocytes constitutively produce but do not process interleukin-18. British Journal of Dermatology 143(2): 330–336.CrossRefPubMed

19.

O’Kane, M., E.P. Murphy, et al. 2006. The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease. Experimental Dermatology 15(3): 143–153.CrossRefPubMed

20.

Ohta, Y., Y. Hamada, et al. 2001. Expression of IL-18 in psoriasis. Archives of Dermatological Research 293(7): 334–342.CrossRefPubMed

21.

Park, H.J., H.J. Kim, et al. 2005. Corticotropin-releasing hormone (CRH) downregulates interleukin-18 expression in human HaCaT keratinocytes by activation of p38 mitogen-activated protein kinase (MAPK) pathway. Journal of Investigative Dermatology 124(4): 751–755.CrossRefPubMed

22.

Pietrzak, A., B. Lecewicz-Torun, et al. 2003. Interleukin-18 levels in the plasma of psoriatic patients correlate with the extent of skin lesions and the PASI score. Acta Dermato-Venereologica 83(4): 262–265.CrossRefPubMed

23.

Pisarchik, A., and A. Slominski. 2004. Molecular and functional characterization of novel CRFR1 isoforms from the skin. European Journal of Biochemistry 271(13): 2821–2830.CrossRefPubMedCentralPubMed

24.

Quevedo, M.E., A. Slominski, et al. 2001. Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. Vitro Cell Development Biological Animation 37(1): 50–54.CrossRef

25.

Raman, M., and M.H. Cobb. 2003. MAP kinase modules: Many roads home. Current Biology 13(22): R886–888.CrossRefPubMed

26.

Robinson, M.J., and M.H. Cobb. 1997. Mitogen-activated protein kinase pathways. Current Opinion in Cell Biology 9(2): 180–186.CrossRefPubMed

27.

Saraceno, R., C.E. Kleyn, et al. 2006. The role of neuropeptides in psoriasis. British Journal of Dermatology 155(5): 876–882.CrossRefPubMed

28.

Schaeffer, H.J., and M.J. Weber. 1999. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers. Molecular and Cellular Biology 19(4): 2435–2444.PubMedCentralPubMed

29.

Seung, N.R., E.J. Park, et al. 2007. Comparison of expression of heat-shock protein 60, Toll-like receptors 2 and 4, and T-cell receptor gammadelta in plaque and guttate psoriasis. Journal of Cutaneous Pathology 34(12): 903–911.CrossRefPubMed

30.

Slominski, A. 2005. Neuroendocrine system of the skin. Dermatology 211(3): 199–208.CrossRefPubMedCentralPubMed

31.

Slominski, A. 2009. On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders. British Journal of Dermatology 160(2): 229–232.CrossRefPubMedCentralPubMed

32.

Slominski, A., A. Pisarchik, et al. 2004. Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology 145(2): 941–950.CrossRefPubMedCentralPubMed

33.

Slominski, A., J. Wortsman, et al. 2000. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiological Reviews 80(3): 979–1020.PubMed

34.

Slominski, A., B. Zbytek, et al. 2006. CRH functions as a growth factor/cytokine in the skin. Journal of Cellular Physiology 206(3): 780–791.CrossRefPubMedCentralPubMed

35.

Slominski, A., B. Zbytek, et al. 2006. Corticotropin releasing hormone and the skin. Frontiers in Bioscience 11: 2230–2248.CrossRefPubMedCentralPubMed

36.

Sugama, S., and B. Conti. 2008. Interleukin-18 and stress. Brain Research Reviews 58(1): 85–95.CrossRefPubMed

37.

Tagen, M., L. Stiles, et al. 2007. Skin corticotropin-releasing hormone receptor expression in psoriasis. Journal of Investigative Dermatology 127(7): 1789–1791.PubMed

38.

Takahashi, H., M. Ibe, et al. 2002. Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis. Journal of Dermatological Science 30(2): 94–99.CrossRefPubMed

39.

Wajant, H., K. Pfizenmaier, et al. 2003. Tumor necrosis factor signaling. Cell Death and Differentiation 10(1): 45–65.CrossRefPubMed

40.

Wang, W., P. Ji, et al. 2003. Corticotropin-releasing hormone induces proliferation and TNF-alpha release in cultured rat microglia via MAP kinase signalling pathways. Journal of Neurochemistry 84(1): 189–195.CrossRefPubMed

41.

Wraight, C.J., M.M. Murashita, et al. 1994. A keratinocyte cell line synthesizes a predominant insulin-like growth factor-binding protein (IGFBP-3) that modulates insulin-like growth factor-I action. Journal of Investigative Dermatology 103(5): 627–631.CrossRefPubMed

42.

Yu, X.J., C.Y. Li, et al. 2007. Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin. Experimental and Molecular Pathology 83(3): 413–418.CrossRefPubMed

43.

Zbytek, B., A. Mysliwski, et al. 2002. Corticotropin-releasing hormone affects cytokine production in human HaCaT keratinocytes. Life Sciences 70(9): 1013–1021.CrossRefPubMed

44.

Zbytek, B., and A.T. Slominski. 2005. Corticotropin-releasing hormone induces keratinocyte differentiation in the adult human epidermis. Journal of Cellular Physiology 203(1): 118–126.CrossRefPubMed

45.

Zhou, C.L., X.J. Yu, et al. 2010. Corticotropin-releasing hormone attenuates vascular endothelial growth factor release from human HaCaT keratinocytes. Regulatory Peptides 160(1–3): 115–20.CrossRefPubMed

46.

Zouboulis, C.C. 2004. The human skin as a hormone target and an endocrine gland. Hormones (Athens, Greece) 3(1): 9–26.CrossRef

Titel: Inhibiting Interleukin-18 Production Through the Mitogen-Activated Protein Kinase Pathway, A Potential Role of Corticotropin-Releasing Hormone in Chronic Plaque Psoriasis
verfasst von: Chun-Lei Zhou
Xiao-Jing Yu
Da-Xing Cai
Yong-Hao Xu
Chun-Yang Li
Qing Sun
Publikationsdatum: 01.06.2015
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 3/2015
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-014-0064-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Inhibiting Interleukin-18 Production Through the Mitogen-Activated Protein Kinase Pathway, A Potential Role of Corticotropin-Releasing Hormone in Chronic Plaque Psoriasis

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2015

Inhibitory Effects of JEUD-38, a New Sesquiterpene Lactone from Inula japonica Thunb, on LPS-Induced iNOS Expression in RAW264.7 Cells

The Anti-inflammatory Effect of the CXCR4 Antagonist-N15P Peptide and Its Modulation on Inflammation-Associated Mediators in LPS-Induced PBMC

Inhibitory Effects of Polydatin on Lipopolysaccharide-Stimulated RAW 264.7 Cells

Selenium Deficiency Facilitates Inflammation Through the Regulation of TLR4 and TLR4-Related Signaling Pathways in the Mice Uterus

Intranasal Curcumin Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice

Bergenin Plays an Anti-Inflammatory Role via the Modulation of MAPK and NF-κB Signaling Pathways in a Mouse Model of LPS-Induced Mastitis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin